Arena Pharmaceuticals (LTS:0S54) Receivables Turnover : 0.00 (As of Dec. 2021)

View and export this data going back to 2018. Start your Free Trial

What is Arena Pharmaceuticals Receivables Turnover?

The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Arena Pharmaceuticals's Revenue for the three months ended in Dec. 2021 was $0.05 Mil. Arena Pharmaceuticals's average Accounts Receivable for the three months ended in Dec. 2021 was $0.00 Mil.

Arena Pharmaceuticals Receivables Turnover Historical Data

The historical data trend for Arena Pharmaceuticals's Receivables Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Arena Pharmaceuticals Receivables Turnover Chart

Arena Pharmaceuticals Annual Data

Trend

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Receivables Turnover

Get a 7-Day Free Trial

14.56

4.83

158.56

Arena Pharmaceuticals Quarterly Data
	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21
Receivables Turnover	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Arena Pharmaceuticals's Receivables Turnover

For the Biotechnology subindustry, Arena Pharmaceuticals's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Arena Pharmaceuticals's Receivables Turnover Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Arena Pharmaceuticals's Receivables Turnover distribution charts can be found below:

* The bar in red indicates where Arena Pharmaceuticals's Receivables Turnover falls into.

Arena Pharmaceuticals Receivables Turnover Calculation

Receivables Turnover measures the number of times a company collects its average accounts receivable balance.

Arena Pharmaceuticals's Receivables Turnover for the fiscal year that ended in Dec. 2021 is calculated as

	Receivables Turnover (A: Dec. 2021 )
=	Revenue	/	Average Total Inventories
=	Revenue (A: Dec. 2021 )	/ (	(Accounts Receivable (A: Dec. 2020 )	+	Accounts Receivable (A: Dec. 2021 ))	/	count )
=	0.054	/ (	(0	+	0)	/	1 )
=	0.054	/	0
=	N/A

Arena Pharmaceuticals's Receivables Turnover for the quarter that ended in Dec. 2021 is calculated as

	Receivables Turnover (Q: Dec. 2021 )
=	Revenue	/	Average Total Inventories
=	Revenue (Q: Dec. 2021 )	/ (	(Accounts Receivable (Q: Sep. 2021 )	+	Accounts Receivable (Q: Dec. 2021 ))	/	count )
=	0.054	/ (	(0	+	0)	/	1 )
=	0.054	/	0
=	N/A

Arena Pharmaceuticals (LTS:0S54) Receivables Turnover Explanation

An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.

Arena Pharmaceuticals Receivables Turnover Related Terms

Thank you for viewing the detailed overview of Arena Pharmaceuticals's Receivables Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.

Arena Pharmaceuticals (LTS:0S54) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Arena Pharmaceuticals Inc (LTS:0S54) » Definitions » Receivables Turnover

Comparable Companies

Traded in Other Exchanges

N/A

Address

136 Heber Avenue, Suite 204, Park City, UT, USA, 84060

Website

https://www.arenapharm.com

Arena Pharmaceuticals is a biotechnology company targeting G-protein-coupled receptors. The company has one internally discovered drug, lorcaserin, which has been approved and is marketed in the U.S. and South Korea to target weight management. It is commercialized under the brand name Belviq. The company is collaborating with Eisai to market Belviq in other countries. It has a presence in Europe through its Swiss subsidiary, Arena GmbH. The company's pipeline contains drugs targeting autoimmune diseases, vascular diseases, thrombotic diseases, dementia-associated psychosis, nervous system issues, and pain.

Arena Pharmaceuticals (LTS:0S54) Headlines

No Headlines